News

Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell model demonstrating that the virus that causes COVID‑19 (SARS-CoV-2) can directly infect heart tissue, providing new insight into why some people experience serious heart complications during and after infection.

Researchers from the University of Sydney and the Centenary Institute have discovered how a promising class of experimental antibiotics disrupts the bacterium that causes tuberculosis (TB), paving the way for urgently needed new treatments.

Researchers at the Centenary Institute, Chris O’Brien Lifehouse, NSW Health Pathology and Royal Prince Alfred Hospital have found a potential new way to help doctors identify which head and neck cancer patients may be at higher risk of their cancer returning, using a simple blood test.

Researchers from the Centenary Institute have developed a new diagnostic tool, the FAP-Index, that could significantly improve how doctors identify people at risk of serious liver damage caused by metabolic fatty liver disease. The condition affects around one in three Australians with cases projected to increase by 25% to over 7 million by 2030.

Centenary Institute researchers have achieved success in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants, securing funding for innovative work in rare genetic diseases and liver disease.

Centenary Institute researchers have uncovered new genetic causes of inherited heart conditions, providing families with vital answers to guide treatment and prevention.

A new study by the Centenary Institute and the Sydney Local Health District has found that a specialised blood test can detect alcohol use in people with liver disease far more accurately than commonly used biomarker tests or patient self-reports. The breakthrough could help clinicians make better treatment decisions and guide eligibility for liver transplants.

A new study led by the Centenary Institute and the University of Sydney shows that a nasal vaccine could offer powerful protection against COVID-19. It works by stopping infection in the nose before the virus spreads through the body.

A breathtaking collection of images capturing the wonder and complexity of medical science has been unveiled through the Centenary Institute’s 2025 When Art Meets Science image prize competition.

The Centenary Institute and Cure The Future Foundation have announced a new philanthropic partnership to accelerate research into life-changing treatments for rare genetic diseases and cancers.

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By targeting features shared by a range of coronaviruses, the vaccine is designed to offer broader and longer-lasting protection as the virus continues to evolve.

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.